Your browser doesn't support javascript.
loading
DNA methylation-based reclassification of olfactory neuroblastoma.
Capper, David; Engel, Nils W; Stichel, Damian; Lechner, Matt; Glöss, Stefanie; Schmid, Simone; Koelsche, Christian; Schrimpf, Daniel; Niesen, Judith; Wefers, Annika K; Jones, David T W; Sill, Martin; Weigert, Oliver; Ligon, Keith L; Olar, Adriana; Koch, Arend; Forster, Martin; Moran, Sebastian; Tirado, Oscar M; Sáinz-Jaspeado, Miguel; Mora, Jaume; Esteller, Manel; Alonso, Javier; Del Muro, Xavier Garcia; Paulus, Werner; Felsberg, Jörg; Reifenberger, Guido; Glatzel, Markus; Frank, Stephan; Monoranu, Camelia M; Lund, Valerie J; von Deimling, Andreas; Pfister, Stefan; Buslei, Rolf; Ribbat-Idel, Julika; Perner, Sven; Gudziol, Volker; Meinhardt, Matthias; Schüller, Ulrich.
Afiliação
  • Capper D; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Engel NW; Department of Neuropathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Stichel D; Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Lechner M; Institute of Neuropathology, Berlin Institute of Health, Berlin, Germany.
  • Glöss S; German Cancer Consortium (DKTK), Partner Site Berlin, Berlin, Germany.
  • Schmid S; Center for Neuropathology, Ludwig-Maximilians-University, Munich, Germany.
  • Koelsche C; Department of Oncology and Hematology with Sections Bone Marrow Transplant and Pneumology, Hubertus Wald Tumorzentrum/University Cancer Center Hamburg, University Medical Center Hamburg, Hamburg, Germany.
  • Schrimpf D; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Niesen J; Royal National Throat, Nose and Ear Hospital, University College London Hospitals NHS Trust, London, UK.
  • Wefers AK; UCL Cancer Institute, University College London, London, UK.
  • Jones DTW; Head and Neck Centre, University College London Hospitals NHS Trust, London, UK.
  • Sill M; Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Weigert O; Institute of Neuropathology, Berlin Institute of Health, Berlin, Germany.
  • Ligon KL; German Cancer Consortium (DKTK), Partner Site Berlin, Berlin, Germany.
  • Olar A; Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Koch A; Institute of Neuropathology, Berlin Institute of Health, Berlin, Germany.
  • Forster M; German Cancer Consortium (DKTK), Partner Site Berlin, Berlin, Germany.
  • Moran S; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Tirado OM; Department of Neuropathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Sáinz-Jaspeado M; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Mora J; Department of Neuropathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Esteller M; Department of Pediatric Hematology and Oncology, University Medical Center, Hamburg-Eppendorf, Germany.
  • Alonso J; Research Institute Children's Cancer Center Hamburg, Hamburg, Germany.
  • Del Muro XG; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Paulus W; Department of Neuropathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Felsberg J; Hopp Children's Cancer Center at the NCT Heidelberg (KiTZ), Heidelberg, Germany.
  • Reifenberger G; Division of Pediatric Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Glatzel M; Hopp Children's Cancer Center at the NCT Heidelberg (KiTZ), Heidelberg, Germany.
  • Frank S; Division of Pediatric Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Monoranu CM; Department of Internal Medicine III, University Hospital of the Ludwig-Maximilians-University Munich, Munich, Germany.
  • Lund VJ; Department of Medical Oncology and Center for Molecular Oncologic Pathology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA, USA.
  • von Deimling A; Departments of Pathology and Laboratory Medicine and Neurosurgery, Medical University of South Carolina and Hollings Cancer Center, Charleston, SC, USA.
  • Pfister S; Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
  • Buslei R; UCL Cancer Institute, University College London, London, UK.
  • Ribbat-Idel J; Head and Neck Centre, University College London Hospitals NHS Trust, London, UK.
  • Perner S; Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.
  • Gudziol V; Sarcoma Research Group, Molecular Oncology Lab, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.
  • Meinhardt M; Sarcoma Research Group, Molecular Oncology Lab, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.
  • Schüller U; Department of Pediatric Onco-Hematology and Developmental Tumor Biology Laboratory, Hospital Sant Joan de Déu, Barcelona, Catalonia, Spain.
Acta Neuropathol ; 136(2): 255-271, 2018 08.
Article em En | MEDLINE | ID: mdl-29730775
ABSTRACT
Olfactory neuroblastoma/esthesioneuroblastoma (ONB) is an uncommon neuroectodermal neoplasm thought to arise from the olfactory epithelium. Little is known about its molecular pathogenesis. For this study, a retrospective cohort of n = 66 tumor samples with the institutional diagnosis of ONB was analyzed by immunohistochemistry, genome-wide DNA methylation profiling, copy number analysis, and in a subset, next-generation panel sequencing of 560 tumor-associated genes. DNA methylation profiles were compared to those of relevant differential diagnoses of ONB. Unsupervised hierarchical clustering analysis of DNA methylation data revealed four subgroups among institutionally diagnosed ONB. The largest group (n = 42, 64%, Core ONB) presented with classical ONB histology and no overlap with other classes upon methylation profiling-based t-distributed stochastic neighbor embedding (t-SNE) analysis. A second DNA methylation group (n = 7, 11%) with CpG island methylator phenotype (CIMP) consisted of cases with strong expression of cytokeratin, no or scarce chromogranin A expression and IDH2 hotspot mutation in all cases. T-SNE analysis clustered these cases together with sinonasal carcinoma with IDH2 mutation. Four cases (6%) formed a small group characterized by an overall high level of DNA methylation, but without CIMP. The fourth group consisted of 13 cases that had heterogeneous DNA methylation profiles and strong cytokeratin expression in most cases. In t-SNE analysis, these cases mostly grouped among sinonasal adenocarcinoma, squamous cell carcinoma, and undifferentiated carcinoma. Copy number analysis indicated highly recurrent chromosomal changes among Core ONB with a high frequency of combined loss of chromosome 1-4, 8-10, and 12. NGS sequencing did not reveal highly recurrent mutations in ONB, with the only recurrently mutated genes being TP53 and DNMT3A. In conclusion, we demonstrate that institutionally diagnosed ONB are a heterogeneous group of tumors. Expression of cytokeratin, chromogranin A, the mutational status of IDH2 as well as DNA methylation patterns may greatly aid in the precise classification of ONB.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Metilação de DNA / Transtornos do Olfato / Neuroblastoma Tipo de estudo: Diagnostic_studies Limite: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Acta Neuropathol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Metilação de DNA / Transtornos do Olfato / Neuroblastoma Tipo de estudo: Diagnostic_studies Limite: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Acta Neuropathol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Alemanha